New Federal Initiatives To Enhance the Medical Treatment of Opioid Dependence
- 15 October 2002
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 137 (8) , 688-692
- https://doi.org/10.7326/0003-4819-137-8-200210150-00014
Abstract
Opioid dependence is a chronic relapsing medical condition with substantial health and societal complications. Recent federal initiatives are designed to enhance the medical treatment of patients with opioid dependence and will expand the role of internists in the care of these patients. These initiatives include a process for federal exemptions to allow for pharmacologic treatment in office settings, waivers for the use of new medications, and new rules governing the oversight and distribution of opioid agonist medications for maintenance treatment. This perspective describes these initiatives and their implications for internists.Keywords
This publication has 26 references indexed in Scilit:
- Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes EvaluationSurvey of Anesthesiology, 2001
- Provision of Methadone Treatment in Primary Care Medical Practices: Review of the Scottish Experience and Implications for US PolicySurvey of Anesthesiology, 2001
- Pharmacologic Treatment of Heroin-Dependent PatientsAnnals of Internal Medicine, 2000
- Treating Major Depression in Primary Care PracticeArchives of General Psychiatry, 1998
- French general practitioners' attitudes toward maintenance drug abuse treatment with buprenorphineAddiction, 1998
- Molecular and Cellular Basis of AddictionScience, 1997
- THE ROLE OF THE GENERALIST IN THE CARE OF THE SUBSTANCE-ABUSING PATIENTMedical Clinics of North America, 1997
- Alcohol Abuse, Other Drug Abuse, and Mental Disorders in Medical PracticePublished by American Medical Association (AMA) ,1986
- Narcotic BlockadeArchives of internal medicine (1960), 1966
- A Medical Treatment for Diacetylmorphine (Heroin) AddictionJAMA, 1965